Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 77 | 2024 | 6457 | 4.220 |
Why?
|
Radiopharmaceuticals | 26 | 2024 | 2634 | 2.860 |
Why?
|
tau Proteins | 13 | 2024 | 2085 | 1.330 |
Why?
|
Carbolines | 7 | 2024 | 286 | 1.250 |
Why?
|
Dopamine | 15 | 2024 | 1599 | 1.190 |
Why?
|
Isoquinolines | 3 | 2024 | 351 | 0.940 |
Why?
|
Receptor, Muscarinic M4 | 1 | 2024 | 16 | 0.930 |
Why?
|
Brain | 38 | 2024 | 26952 | 0.850 |
Why?
|
Macaca mulatta | 9 | 2024 | 2316 | 0.820 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2019 | 415 | 0.780 |
Why?
|
Neurotransmitter Agents | 4 | 2011 | 663 | 0.760 |
Why?
|
Alzheimer Disease | 11 | 2024 | 8545 | 0.720 |
Why?
|
Receptors, Metabotropic Glutamate | 4 | 2022 | 195 | 0.700 |
Why?
|
Carbon Radioisotopes | 6 | 2024 | 557 | 0.650 |
Why?
|
Receptor, Cannabinoid, CB1 | 3 | 2015 | 137 | 0.650 |
Why?
|
Fluorine Radioisotopes | 8 | 2021 | 413 | 0.640 |
Why?
|
Neostriatum | 1 | 2019 | 246 | 0.600 |
Why?
|
Raclopride | 10 | 2022 | 101 | 0.580 |
Why?
|
Zirconium | 2 | 2020 | 107 | 0.520 |
Why?
|
Tauopathies | 4 | 2024 | 317 | 0.520 |
Why?
|
Autopsy | 1 | 2019 | 1003 | 0.510 |
Why?
|
Molecular Imaging | 3 | 2022 | 813 | 0.490 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2021 | 2004 | 0.490 |
Why?
|
Synaptic Transmission | 1 | 2020 | 1168 | 0.460 |
Why?
|
Hot Temperature | 3 | 2018 | 1434 | 0.430 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2023 | 8946 | 0.420 |
Why?
|
Basal Ganglia | 3 | 2013 | 553 | 0.420 |
Why?
|
Cell Division | 1 | 2020 | 4459 | 0.410 |
Why?
|
Tetrabenazine | 1 | 2012 | 18 | 0.410 |
Why?
|
Radioactive Tracers | 2 | 2022 | 66 | 0.390 |
Why?
|
Cell Cycle | 1 | 2020 | 2929 | 0.390 |
Why?
|
Depressive Disorder, Major | 4 | 2024 | 4744 | 0.390 |
Why?
|
Autoradiography | 5 | 2019 | 730 | 0.380 |
Why?
|
Ferrosoferric Oxide | 4 | 2021 | 348 | 0.380 |
Why?
|
Metal Nanoparticles | 1 | 2015 | 397 | 0.370 |
Why?
|
Demyelinating Diseases | 2 | 2022 | 351 | 0.350 |
Why?
|
Cerebral Angiography | 1 | 2015 | 1275 | 0.330 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2378 | 0.320 |
Why?
|
Tissue Distribution | 6 | 2022 | 2263 | 0.320 |
Why?
|
Kinetics | 7 | 2024 | 6371 | 0.310 |
Why?
|
Magnetite Nanoparticles | 2 | 2020 | 315 | 0.310 |
Why?
|
Radioisotopes | 3 | 2020 | 495 | 0.310 |
Why?
|
Models, Neurological | 3 | 2013 | 1757 | 0.310 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2020 | 570 | 0.310 |
Why?
|
Potassium Channels | 2 | 2021 | 534 | 0.300 |
Why?
|
Insulin-Secreting Cells | 2 | 2012 | 896 | 0.300 |
Why?
|
Dopamine Antagonists | 6 | 2013 | 288 | 0.280 |
Why?
|
Central Nervous System Depressants | 3 | 2016 | 164 | 0.280 |
Why?
|
Monocytes | 1 | 2015 | 2568 | 0.260 |
Why?
|
4-Aminopyridine | 2 | 2022 | 80 | 0.250 |
Why?
|
Computer Simulation | 6 | 2020 | 6198 | 0.250 |
Why?
|
Ethanol | 5 | 2016 | 1324 | 0.250 |
Why?
|
Lactams, Macrocyclic | 2 | 2017 | 315 | 0.250 |
Why?
|
Microdialysis | 3 | 2011 | 160 | 0.240 |
Why?
|
Animals | 45 | 2024 | 167718 | 0.240 |
Why?
|
Sex Characteristics | 1 | 2015 | 2621 | 0.240 |
Why?
|
Cyclic S-Oxides | 1 | 2024 | 25 | 0.230 |
Why?
|
Cell Proliferation | 1 | 2020 | 10405 | 0.230 |
Why?
|
Corpus Striatum | 5 | 2024 | 1233 | 0.230 |
Why?
|
Azabicyclo Compounds | 1 | 2024 | 68 | 0.230 |
Why?
|
Membrane Potential, Mitochondrial | 3 | 2021 | 293 | 0.220 |
Why?
|
Kv1.2 Potassium Channel | 1 | 2022 | 15 | 0.210 |
Why?
|
Kv1.1 Potassium Channel | 1 | 2022 | 30 | 0.210 |
Why?
|
Receptors, Opioid, mu | 1 | 2024 | 166 | 0.210 |
Why?
|
Receptors, Opioid, kappa | 1 | 2024 | 138 | 0.210 |
Why?
|
Magnetic Resonance Imaging | 12 | 2024 | 36270 | 0.210 |
Why?
|
Allosteric Regulation | 1 | 2024 | 426 | 0.210 |
Why?
|
Neurodegenerative Diseases | 2 | 2024 | 1081 | 0.200 |
Why?
|
Succinimides | 1 | 2021 | 81 | 0.200 |
Why?
|
Pyrans | 1 | 2022 | 49 | 0.200 |
Why?
|
Picolinic Acids | 1 | 2022 | 50 | 0.200 |
Why?
|
Aminopyridines | 3 | 2020 | 564 | 0.190 |
Why?
|
Sulfonic Acids | 1 | 2021 | 102 | 0.190 |
Why?
|
Rats | 15 | 2022 | 23676 | 0.190 |
Why?
|
Isotope Labeling | 2 | 2020 | 392 | 0.190 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2021 | 202 | 0.190 |
Why?
|
Cromolyn Sodium | 1 | 2021 | 77 | 0.180 |
Why?
|
Placebo Effect | 1 | 2024 | 518 | 0.180 |
Why?
|
Organophosphorus Compounds | 1 | 2021 | 203 | 0.170 |
Why?
|
Fragile X Syndrome | 1 | 2021 | 116 | 0.170 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2017 | 1110 | 0.170 |
Why?
|
Humans | 58 | 2024 | 757566 | 0.160 |
Why?
|
Carbon Isotopes | 3 | 2015 | 458 | 0.160 |
Why?
|
Tissue Banks | 1 | 2019 | 184 | 0.160 |
Why?
|
Dopamine Agents | 1 | 2019 | 189 | 0.160 |
Why?
|
Blood-Brain Barrier | 2 | 2022 | 1017 | 0.150 |
Why?
|
Nanoparticles | 3 | 2020 | 1939 | 0.150 |
Why?
|
Cerebrovascular Circulation | 3 | 2023 | 2725 | 0.150 |
Why?
|
Phantoms, Imaging | 5 | 2023 | 2509 | 0.150 |
Why?
|
Receptors, Dopamine D3 | 2 | 2022 | 108 | 0.150 |
Why?
|
Myocardium | 3 | 2021 | 4690 | 0.150 |
Why?
|
Ligands | 4 | 2022 | 3257 | 0.150 |
Why?
|
Male | 40 | 2024 | 358180 | 0.150 |
Why?
|
Aniline Compounds | 1 | 2023 | 1068 | 0.150 |
Why?
|
Coronary Circulation | 3 | 2020 | 1561 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2012 | 3432 | 0.140 |
Why?
|
Football | 1 | 2023 | 502 | 0.140 |
Why?
|
Coronary Vessels | 2 | 2020 | 3072 | 0.140 |
Why?
|
Reproducibility of Results | 8 | 2020 | 20037 | 0.140 |
Why?
|
Radiometry | 1 | 2022 | 813 | 0.140 |
Why?
|
Neuralgia | 1 | 2023 | 600 | 0.140 |
Why?
|
Individuality | 1 | 2018 | 300 | 0.140 |
Why?
|
Apolipoprotein E4 | 1 | 2021 | 706 | 0.140 |
Why?
|
Phosphatidylcholines | 1 | 2018 | 405 | 0.140 |
Why?
|
Click Chemistry | 1 | 2017 | 95 | 0.140 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 203 | 0.130 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 361 | 0.130 |
Why?
|
Models, Biological | 3 | 2016 | 9459 | 0.130 |
Why?
|
Mitochondria | 2 | 2020 | 3583 | 0.130 |
Why?
|
Cocaine | 2 | 2019 | 958 | 0.130 |
Why?
|
Oxygen Radioisotopes | 1 | 2015 | 75 | 0.130 |
Why?
|
Rest | 2 | 2017 | 914 | 0.130 |
Why?
|
Microglia | 2 | 2022 | 1347 | 0.120 |
Why?
|
Doxorubicin | 1 | 2022 | 2211 | 0.120 |
Why?
|
Pyridazines | 1 | 2017 | 200 | 0.120 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 872 | 0.120 |
Why?
|
Oxazoles | 1 | 2016 | 199 | 0.120 |
Why?
|
Nanostructures | 2 | 2017 | 546 | 0.120 |
Why?
|
Deferoxamine | 1 | 2015 | 153 | 0.120 |
Why?
|
Neurofibrillary Tangles | 1 | 2017 | 457 | 0.120 |
Why?
|
Amyloid beta-Peptides | 6 | 2023 | 3826 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 7 | 2022 | 8143 | 0.120 |
Why?
|
Receptors, Dopamine D2 | 2 | 2016 | 485 | 0.120 |
Why?
|
Iron Chelating Agents | 1 | 2015 | 138 | 0.120 |
Why?
|
HeLa Cells | 1 | 2020 | 3096 | 0.110 |
Why?
|
Contrast Media | 3 | 2022 | 5297 | 0.110 |
Why?
|
Swine | 6 | 2020 | 5891 | 0.110 |
Why?
|
Alcoholism | 2 | 2016 | 1965 | 0.110 |
Why?
|
Wireless Technology | 1 | 2014 | 98 | 0.110 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1065 | 0.110 |
Why?
|
Head Movements | 1 | 2014 | 152 | 0.110 |
Why?
|
Adult | 21 | 2024 | 219725 | 0.100 |
Why?
|
Female | 25 | 2024 | 389943 | 0.100 |
Why?
|
Flumazenil | 1 | 2012 | 84 | 0.100 |
Why?
|
Brain Concussion | 1 | 2023 | 1397 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2864 | 0.100 |
Why?
|
Reward | 1 | 2018 | 965 | 0.100 |
Why?
|
Neuroglia | 1 | 2017 | 943 | 0.100 |
Why?
|
Organ Specificity | 1 | 2016 | 1955 | 0.100 |
Why?
|
Alcoholic Intoxication | 2 | 2016 | 174 | 0.100 |
Why?
|
Middle Aged | 16 | 2024 | 219192 | 0.090 |
Why?
|
Alcohol Drinking | 3 | 2016 | 4019 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 902 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2017 | 2419 | 0.090 |
Why?
|
Locus Coeruleus | 2 | 2023 | 230 | 0.090 |
Why?
|
Dopamine Agonists | 1 | 2013 | 352 | 0.090 |
Why?
|
Algorithms | 6 | 2023 | 13952 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
Aged | 13 | 2023 | 167890 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1505 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5638 | 0.090 |
Why?
|
Movement | 1 | 2016 | 1475 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2017 | 1399 | 0.080 |
Why?
|
Extracellular Space | 1 | 2011 | 564 | 0.080 |
Why?
|
Motion | 2 | 2023 | 779 | 0.080 |
Why?
|
Chromatography, Gel | 2 | 2020 | 645 | 0.080 |
Why?
|
Macaca fascicularis | 2 | 2022 | 900 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1623 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1088 | 0.080 |
Why?
|
Brain Injuries | 1 | 2020 | 2045 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4456 | 0.080 |
Why?
|
Receptors, Dopamine | 2 | 2006 | 293 | 0.080 |
Why?
|
Prefrontal Cortex | 1 | 2018 | 2209 | 0.080 |
Why?
|
Alcohols | 1 | 2008 | 94 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4492 | 0.070 |
Why?
|
Permeability | 2 | 2022 | 718 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3560 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8426 | 0.070 |
Why?
|
Mice | 9 | 2022 | 81066 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14637 | 0.070 |
Why?
|
Lactams | 2 | 2017 | 154 | 0.070 |
Why?
|
Wound Healing | 1 | 2017 | 2781 | 0.070 |
Why?
|
Pyrimidines | 2 | 2017 | 3005 | 0.070 |
Why?
|
Models, Statistical | 3 | 2011 | 5068 | 0.070 |
Why?
|
Reference Standards | 3 | 2017 | 1003 | 0.070 |
Why?
|
Methamphetamine | 1 | 2008 | 165 | 0.060 |
Why?
|
Young Adult | 8 | 2024 | 58755 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2023 | 58558 | 0.060 |
Why?
|
Cerebral Arteries | 1 | 2007 | 490 | 0.060 |
Why?
|
Peptide Fragments | 2 | 2021 | 5095 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4918 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4737 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1345 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2007 | 959 | 0.060 |
Why?
|
Skin | 1 | 2017 | 4464 | 0.060 |
Why?
|
Brain Mapping | 3 | 2018 | 6571 | 0.060 |
Why?
|
Monoamine Oxidase | 1 | 2024 | 176 | 0.060 |
Why?
|
Cues | 1 | 2008 | 869 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2017 | 2864 | 0.050 |
Why?
|
Head | 1 | 2008 | 921 | 0.050 |
Why?
|
Photic Stimulation | 1 | 2008 | 1967 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25924 | 0.050 |
Why?
|
Melanins | 1 | 2024 | 289 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18114 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3047 | 0.050 |
Why?
|
Pyrazoles | 3 | 2017 | 1992 | 0.050 |
Why?
|
Linear Models | 1 | 2011 | 5856 | 0.050 |
Why?
|
Radiochemistry | 1 | 2021 | 49 | 0.050 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 116 | 0.050 |
Why?
|
Mitochondria, Heart | 1 | 2022 | 229 | 0.050 |
Why?
|
Cricetulus | 1 | 2022 | 815 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2008 | 1491 | 0.040 |
Why?
|
Neural Pathways | 2 | 2024 | 3040 | 0.040 |
Why?
|
Feasibility Studies | 3 | 2020 | 5194 | 0.040 |
Why?
|
Chromatography, Thin Layer | 1 | 2020 | 212 | 0.040 |
Why?
|
Haplorhini | 1 | 2021 | 529 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 419 | 0.040 |
Why?
|
Primates | 1 | 2022 | 523 | 0.040 |
Why?
|
Lutetium | 1 | 2020 | 34 | 0.040 |
Why?
|
Entorhinal Cortex | 1 | 2022 | 286 | 0.040 |
Why?
|
Nitrogen Isotopes | 1 | 2020 | 84 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4901 | 0.040 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5756 | 0.040 |
Why?
|
Copper Radioisotopes | 1 | 2020 | 89 | 0.040 |
Why?
|
Rats, Wistar | 2 | 2015 | 1841 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20499 | 0.040 |
Why?
|
Ammonia | 1 | 2020 | 236 | 0.040 |
Why?
|
Fluoroacetates | 1 | 2018 | 14 | 0.040 |
Why?
|
Cricetinae | 1 | 2022 | 2427 | 0.040 |
Why?
|
Atrophy | 1 | 2023 | 1627 | 0.040 |
Why?
|
Iron Radioisotopes | 1 | 2018 | 19 | 0.040 |
Why?
|
Chelating Agents | 1 | 2020 | 383 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2022 | 675 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2021 | 576 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3524 | 0.040 |
Why?
|
Conditioning, Operant | 1 | 2018 | 309 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2018 | 5861 | 0.040 |
Why?
|
Membrane Potentials | 1 | 2020 | 1094 | 0.040 |
Why?
|
Adolescent | 3 | 2015 | 87819 | 0.030 |
Why?
|
Microspheres | 1 | 2020 | 787 | 0.030 |
Why?
|
Radioligand Assay | 1 | 2017 | 366 | 0.030 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2017 | 80 | 0.030 |
Why?
|
Smoking | 1 | 2013 | 9036 | 0.030 |
Why?
|
Tritium | 1 | 2017 | 707 | 0.030 |
Why?
|
Choline | 1 | 2018 | 513 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2020 | 1485 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2048 | 0.030 |
Why?
|
Memory Disorders | 1 | 2023 | 1198 | 0.030 |
Why?
|
TDP-43 Proteinopathies | 1 | 2015 | 38 | 0.030 |
Why?
|
Phosphorylation | 2 | 2017 | 8296 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10709 | 0.030 |
Why?
|
Fluorescence | 1 | 2018 | 751 | 0.030 |
Why?
|
Electric Power Supplies | 1 | 2015 | 98 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2013 | 4553 | 0.030 |
Why?
|
Adenosine | 1 | 2020 | 802 | 0.030 |
Why?
|
Time Factors | 3 | 2012 | 39811 | 0.030 |
Why?
|
Biochemical Phenomena | 1 | 2015 | 58 | 0.030 |
Why?
|
Phagocytosis | 1 | 2021 | 1532 | 0.030 |
Why?
|
Carbocyanines | 1 | 2015 | 175 | 0.030 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2015 | 102 | 0.030 |
Why?
|
Breath Tests | 1 | 2016 | 296 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2016 | 196 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2016 | 407 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2022 | 1688 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11063 | 0.030 |
Why?
|
Inclusion Bodies | 1 | 2015 | 281 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2021 | 956 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2015 | 488 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2011 | 5083 | 0.030 |
Why?
|
Thigh | 1 | 2015 | 241 | 0.030 |
Why?
|
Palmitic Acids | 1 | 2013 | 52 | 0.030 |
Why?
|
Polyunsaturated Alkamides | 1 | 2013 | 29 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 6230 | 0.030 |
Why?
|
Glycerides | 1 | 2013 | 67 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2022 | 1655 | 0.030 |
Why?
|
Papio | 1 | 2014 | 662 | 0.030 |
Why?
|
Plaque, Amyloid | 1 | 2017 | 759 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3338 | 0.030 |
Why?
|
Ethanolamines | 1 | 2013 | 153 | 0.030 |
Why?
|
Receptors, GABA | 1 | 2014 | 305 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 2013 | 294 | 0.030 |
Why?
|
Markov Chains | 1 | 2016 | 965 | 0.030 |
Why?
|
Endocannabinoids | 1 | 2013 | 111 | 0.030 |
Why?
|
Molecular Structure | 1 | 2016 | 1862 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1846 | 0.020 |
Why?
|
Nerve Net | 1 | 2024 | 2264 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10749 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 1975 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1966 | 0.020 |
Why?
|
Cadaver | 1 | 2015 | 1345 | 0.020 |
Why?
|
Putamen | 1 | 2012 | 291 | 0.020 |
Why?
|
Safety | 1 | 2015 | 1147 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21990 | 0.020 |
Why?
|
Uncertainty | 1 | 2016 | 750 | 0.020 |
Why?
|
Protein Binding | 2 | 2014 | 9312 | 0.020 |
Why?
|
Rats, Zucker | 1 | 2010 | 131 | 0.020 |
Why?
|
Amides | 1 | 2013 | 447 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2022 | 22022 | 0.020 |
Why?
|
Amyloid | 1 | 2015 | 839 | 0.020 |
Why?
|
Streptozocin | 1 | 2010 | 193 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12261 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2014 | 1539 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3799 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 1897 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1895 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 820 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5031 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1256 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3757 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2011 | 297 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1188 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1976 | 0.020 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2011 | 363 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3573 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3600 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4772 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7584 | 0.020 |
Why?
|
Microfluidics | 1 | 2014 | 652 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2318 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2847 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5781 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1178 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2008 | 163 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2203 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7225 | 0.020 |
Why?
|
Fingers | 1 | 2010 | 506 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5732 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15587 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9574 | 0.020 |
Why?
|
Insulin | 2 | 2011 | 6578 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2008 | 278 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 21986 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5406 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2008 | 549 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 2012 | 1115 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9514 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6757 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2012 | 1419 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2013 | 1802 | 0.020 |
Why?
|
Artifacts | 1 | 2014 | 1894 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2017 | 3806 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18936 | 0.020 |
Why?
|
Video Recording | 1 | 2010 | 955 | 0.010 |
Why?
|
Piperidines | 1 | 2013 | 1639 | 0.010 |
Why?
|
Amygdala | 1 | 2012 | 1351 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11890 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2696 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9263 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8049 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2007 | 2212 | 0.010 |
Why?
|
Dementia | 1 | 2015 | 2649 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2011 | 6014 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6363 | 0.010 |
Why?
|
Motor Activity | 1 | 2010 | 2685 | 0.010 |
Why?
|
Hippocampus | 1 | 2012 | 3739 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15781 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54092 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16881 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13221 | 0.010 |
Why?
|
Cerebellum | 1 | 2005 | 1497 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4046 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 7012 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7502 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41190 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 6956 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6152 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15207 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 29929 | 0.010 |
Why?
|